Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ABSTRACT


01 octubre 2015

JOURNAL OF ENDOVASCULAR THERAPY. A Comparison of Clinical Outcomes for Diabetic and Nondiabetic Patients Following Directional Atherectomy in the DEFINITIVE LE Claudicant Cohort

Lawrence A. Garcia, MD⇑1 Michael R. Jaff, DO2 Krishna J. Rocha-Singh, MD3 Thomas Zeller, MD4 Christopher Bosarge, MD5 Suraj Kamat, MD6 James F. McKinsey, MD7

Purpose: To report a subset analysis that evaluated the hypothesis that directional atherectomy for peripheral artery disease in diabetic claudicants has noninferior primary patency at 12 months compared with nondiabetic claudicants.

01 octubre 2015

JOURNAL OF ENDOVASCULAR THERAPY. Histopathological Evidence of Adventitial or Medial Injury Is a Strong Predictor of Restenosis During Directional Atherectomy for Peripheral Artery Disease

Arthur Tarricone, MPH1 Ziad Ali, MD2 Anitha Rajamanickam, MD1 Karthik Gujja, MD1 Vishal Kapur, MD1 K-Raman Purushothaman, MD1 Meerarani Purushothaman, MD1 Miguel Vasquez, MD1 Adrian Zalewski, BS2 Micheal Parides, PhD1 Jessica Overbey, MS1 Jose Wiley, MD1 Prakash Krishnan, MD⇑1

Purpose: To investigate the impact on restenosis rates of deep injury to the adventitial layer during directional atherectomy.

01 octubre 2015

JOURNAL OF ENDOVASCULAR THERAPY. Predictors of 2-Year Mortality and Risk Stratification After Surgical or Endovascular Revascularization of Infrainguinal Artery Disease in Hemodialysis Patients With Critical Limb Ischemia

Tatsuya Shiraki, MD1 Osamu Iida, MD⇑1 Mitsuyoshi Takahara, MD, PhD2 Yoshimitsu Soga, MD, PhD3 Shinsuke Mii, MD, PhD4 Jin Okazaki, MD, PhD5 Sosei Kuma, MD, PhD5 Terutoshi Yamaoka, MD, PhD6 Daisuke Kamoi, MD7 Yoshiaki Shintani, MD8 Toshinobu Ishikawa, MD9 Ikuro Kitano, MD, PhD10 Masaaki Uematsu, MD, PhD1

Purpose: To examine the 2-year mortality in hemodialysis (HD) patients with critical limb ischemia (CLI) and determine predictors that may aid in the selection of a revascularization strategy [bypass surgery or endovascular therapy (EVT)] according to current guidelines.

01 agosto 2015

JOURNAL OF ENDOVASCULAR THERAPY. Drug-Eluting Balloon Therapy for Femoropopliteal Occlusive Disease Predictors of Outcome With a Special Emphasis on Calcium

Gunnar Tepe, MD⇑1 Ulrich Beschorner, MD2 Charlotte Ruether, MD1 Imma Fischer, PhD3 Peter Pfaffinger, MD1 Elias Noory, MD2 Thomas Zeller, MD2

Purpose: To assess the association of patient, lesion, and procedure variables, including calcification, with late lumen loss (LLL) after use of drug-eluting balloon (DEB) therapy in patients with femoropopliteal arterial disease.

01 agosto 2015

JOURNAL OF ENDOVASCULAR THERAPY. Late Rupture of Abdominal Aortic Aneurysm After Previous Endovascular Repair A Systematic Review and Meta-analysis

George A. Antoniou, MD, PhD, MSc, FEBVS⇑1 George S. Georgiadis, MD, PhD2 Stavros A. Antoniou, MD, PhD3 Simon Neequaye, MSc, BSc, FRCS1 John A. Brennan, MD, FRCS1 Francesco Torella, MD, FRCS1 S. Rao Vallabhaneni, MD, FRCS, FEBVS1

Purpose: To report a systematic literature review of late rupture of abdominal aortic aneurysm (AAA) after endovascular aneurysm repair (EVAR) and the results of a pooled analysis of causes, treatment, and outcomes.

01 octubre 2015

JOURNAL OF ENDOVASCULAR THERAPY. Through-Plane Movement at Multiple Aortic Levels on Dynamic Computed Tomography Angiography Is Limited in Patients With an Abdominal Aortic Aneurysm

Jeroen C. de Jonge, MD1 Herman J.A. Zandvoort, MD, PhD1 Evert-Jan P.A. Vonken, MD, PhD2 Frans L. Moll, MD, PhD1 Joost A. van Herwaarden, MD, PhD⇑1

Purpose: To analyze the movement of the aorta in the craniocaudal direction (through-plane movement) during the cardiac cycle at several levels to determine any potential impact on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysm (AAA).

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.